YU44687B - Process for making alive purified vaccine for marek's disseases - Google Patents

Process for making alive purified vaccine for marek's disseases

Info

Publication number
YU44687B
YU44687B YU599/85A YU59985A YU44687B YU 44687 B YU44687 B YU 44687B YU 599/85 A YU599/85 A YU 599/85A YU 59985 A YU59985 A YU 59985A YU 44687 B YU44687 B YU 44687B
Authority
YU
Yugoslavia
Prior art keywords
marek
disease
virus
mdv
vaccine
Prior art date
Application number
YU599/85A
Other languages
English (en)
Other versions
YU59985A (en
Inventor
Boer G F De
Original Assignee
Central Diergeneeskundig Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Diergeneeskundig Inst filed Critical Central Diergeneeskundig Inst
Publication of YU59985A publication Critical patent/YU59985A/xx
Publication of YU44687B publication Critical patent/YU44687B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/816Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
YU599/85A 1984-04-09 1985-04-09 Process for making alive purified vaccine for marek's disseases YU44687B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (2)

Publication Number Publication Date
YU59985A YU59985A (en) 1988-06-30
YU44687B true YU44687B (en) 1990-12-31

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
YU599/85A YU44687B (en) 1984-04-09 1985-04-09 Process for making alive purified vaccine for marek's disseases

Country Status (17)

Country Link
US (1) US4673572A (cs)
EP (1) EP0159743B1 (cs)
JP (1) JPS6123A (cs)
AT (1) ATE56364T1 (cs)
AU (1) AU574164B2 (cs)
CA (1) CA1251397A (cs)
DD (1) DD232822A5 (cs)
DE (1) DE3579617D1 (cs)
ES (1) ES8605680A1 (cs)
HU (1) HU194496B (cs)
IL (1) IL74809A (cs)
IN (1) IN163229B (cs)
MX (1) MX7718E (cs)
NL (1) NL8401120A (cs)
WO (1) WO1985004588A1 (cs)
YU (1) YU44687B (cs)
ZA (1) ZA852564B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
US5993822A (en) * 1996-06-04 1999-11-30 University Of Georgia Research Foundation, Inc. Modified live avian polymavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
RU2144377C1 (ru) * 1999-06-28 2000-01-20 Всероссийский научно-исследовательский институт защиты животных Бивалентная вакцина против болезни марека и способ ее изготовления
US20130251737A1 (en) 2012-03-22 2013-09-26 Merial Limited Modified Mareks Disease Virus, and Vaccines Made Therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
DD232822A5 (de) 1986-02-12
HUT38542A (en) 1986-06-30
CA1251397A (en) 1989-03-21
ZA852564B (en) 1985-11-27
JPH0317808B2 (cs) 1991-03-11
ES8605680A1 (es) 1986-04-16
IN163229B (cs) 1988-08-27
US4673572A (en) 1987-06-16
IL74809A (en) 1990-09-17
AU4156185A (en) 1985-11-01
JPS6123A (ja) 1986-01-06
WO1985004588A1 (en) 1985-10-24
YU59985A (en) 1988-06-30
AU574164B2 (en) 1988-06-30
MX7718E (es) 1990-10-10
EP0159743B1 (en) 1990-09-12
EP0159743A1 (en) 1985-10-30
DE3579617D1 (de) 1990-10-18
IL74809A0 (en) 1985-07-31
HU194496B (en) 1988-02-29
NL8401120A (nl) 1985-11-01
ATE56364T1 (de) 1990-09-15
ES541930A0 (es) 1986-04-16

Similar Documents

Publication Publication Date Title
YU44687B (en) Process for making alive purified vaccine for marek's disseases
Takahashi et al. Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2
ES8401128A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral.
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
US3674861A (en) Live attenuated marek{40 s disease virus vaccine for poultry
US5686287A (en) Marek's disease virus vaccine
Whetstone et al. Changes in the bovine herpesvirus 1 genome during acute infection, after reactivation from latency, and after superinfection in the host animal
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
EP0775743A2 (en) Sustainable chick cell line infected with Marek's disease virus
DE68929181T2 (de) Virale nucleotidsequenzen
US4895718A (en) Serotype 2 Marek's disease vaccine
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
US5149530A (en) Live newcastle disease virus vaccines
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
EP0591384B1 (en) Attenuated revertant serotype 1 marek's disease vaccine
Jeffries et al. Atypical menaquinone pattern in a strain of Staphylococcus aureus
JPS5756430A (en) Live virus vaccine for canine parainfluenza
EP0703294A1 (en) Marek's disease virus vaccine
El‐Zein et al. Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture
MX9702769A (es) Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.
Allison Tumour Viruses: Are Observations on Tumour Viruses in Animals Applicable to Man?
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
SU1707075A1 (ru) Штамм вируса болезни Марека дл изготовлени вакцины против болезни Марека
Shibuta Production of pertussis toxin mutant protein by Bordetella pertussis variant for use in whooping cough vaccine preparation
RO96364B1 (ro) PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK